Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

Sarcura

Financiado

Cell Factory on chips: make Cell Therapies affordable and accessible to all pati...

Cell Factory on chips: make Cell Therapies affordable and accessible to all patients Sarcura GmbH, an Austrian deep-tech company founded in November 2019, will develop and market a machine platform for the industrial GMP manufacturing of personalised cell therapeutics, such as CAR-T therapies. We will contribute... ver más

31/05/2024

Sarcura GmbH

75K€

Presupuesto del proyecto: 75K€

Líder del proyecto

SARCURA GMBH No se ha especificado una descripción o un objeto social para esta compañía.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-05-31

HORIZON-EIE-2022-SCALEUP-02-02: Women TechEU ExpectedOutcome:Project results are expected to contribute to the following expected outcomes:

Innovación

Cerrada hace 2 años

0% 100% 100%

1 Participantes

Sarcura GmbH

75.00K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PAT4CGT Automated online monitoring & control to improve processes a... 4M€ Cerrado

CoDiBio Continuous Digitalized Processes for Producing Biopharmaceut... 3M€ Cerrado

BIO2012-31251 DESARROLLO Y OPTIMIZACION DE BIOPROCESOS PARA LA PRODUCCION... 176K€ Cerrado

PCI2024-153423 Herramientas diagnósticas, pronósticas y terapéuticas 315K€ Cerrado

PMed Enabling patient specific medicines using 3D printing in hos... 4M€ Cerrado

PTQ2020-010953 Sistemas de Producción Industrial de Dispositivos Microfluíd... 116K€ Cerrado

Duración del proyecto: 12 meses Fecha Inicio: 2023-05-26
Fecha Fin: 2024-05-31

Líder del proyecto

SARCURA GMBH No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 75K€

Descripción del proyecto Sarcura GmbH, an Austrian deep-tech company founded in November 2019, will develop and market a machine platform for the industrial GMP manufacturing of personalised cell therapeutics, such as CAR-T therapies. We will contribute to scale the global cell therapy manufacturing capacity of these lifesaving treatments from currently thousands of doses per year to hundreds of thousands of doses, cost effective and safe for all patients. Sarcura envisions to transform existing manufacturing paradigms by using leading-edge semiconductor technologies (such as integrated photonics) embedded in microfluidic liquid processing systems to bring bioprocess control to cellular level. We believe that only by bringing together automation, integration (of additional functionality), miniaturization, and modularity we can achieve the required 100-fold increase in manufacturing capacity the cell therapy industry requires Our initial focus is the development of a GMP ready, fully automated, industrial cell isolation device for the manufacturing of cell therapies. The device will include all necessary processing steps to handle the typical starting material of clinical cell therapy as well as provide integrated process analytics and quality control such as cell count, viability, phenotype characterization and other analytics After launching the first single unit operation device for the Cell Isolation, further devices performing the Formulation, Gene Transfer and Expansion followed by an integrated end-to-end device will be developed. Finally, we aim to market an autonomous, self-optimising manufacturing system based on real-time manufacturing optimisation via AI driven (artificial intelligence) predictive process control. Our product offer will include (a) desktop instruments, (b) single-use microfluidic cartridges, and (c) software and algorithms.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores